| Date | Company | Compound | Disease | Type of agreement | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2015-02-13 | Merck KGaA (Germany) BMS (USA - NY) | Erbitux® | metastatic colorectal cancer, head and neck cancer | distribution |
Cancer - Oncology | Distribution agreement |
| 2015-02-13 | Sage Therapeutics (USA - MA) | nomination |
Nomination | |||
| 2015-02-13 | DBV Technologies (France) | nomination |
Allergic diseases - Immunological diseases | Nomination | ||
| 2015-02-12 | Tigenix (Belgium) Lonza (Switzerland) | Cx601 (adipose derived allogeneic stem cell therapy) | complex perianal fistulas in patients with Crohn\'s disease | manufacturing production |
Autoimmune diseases - Inflammatory diseases - Digestive diseases | Production agreement |
| 2015-02-12 | Janssen Research & Development, a J&J company (USA - NJ) | new research platforms | launch of new research platforms |
Opening of new premises | ||
| 2015-02-12 | OncoGenex Pharmaceuticals (USA - WA) | opening of new premises - relocation |
Opening of new premises | |||
| 2015-02-11 | Pfizer\'s Center for Therapeutic Innovation (USA - NY) Alzheimer\'s Drug Discovery Foundation (USA - NY) | new small-molecule drugs | Alzheimer\'s disease and related dementias | collaboration |
Neurodegenerative diseases | Collaboration agreement |
| 2015-02-11 | Exact Sciences Corporation (USA - WI) | nomination |
Diagnostic - Cancer - Oncology | Nomination | ||
| 2015-02-11 | Blueprint Medicines (USA - MA) | nomination |
Cancer - Oncology - Genetic diseases | Nomination | ||
| 2015-02-10 | Novo Nordisk (Denmark) Karolinska Institutet (Sweden) | diabetes | collaboration |
Metabolic diseases | Collaboration agreement | |
| 2015-02-10 | Onxeo (France) | nomination |
Cancer - Oncology - Rare diseases | Nomination | ||
| 2015-02-10 | Boehringer Ingelheim (Germany) VTU Technology (Austria) | Pichia pastoris technology | collaboration |
Technology - Services | Collaboration agreement | |
| 2015-02-09 | Cerenis Therapeutics (France) | nomination |
Cardiovascular diseases | Nomination | ||
| 2015-02-09 | ALK Abello (Denmark) bioCSL (Australia) | sublingual allergy immunotherapy tablets (SLIT-tablets) for house dust mite (HDM) allergy and grass pollen allergy (Grazax® in Europe and Grastek® in North America), and the adrenaline auto-injector, Jext® | house dust mite allergy, grass pollen allergy, allergic rhinitis | licensing | Allergic diseases - Immunological diseases | Licensing agreement |
| 2015-02-09 | Juno Therapeutics (USA - WA) | facility in Bothell | opening of new premises | Cancer - Oncology | Opening of new premises | |
| 2015-02-09 | Panoptes Pharma (Austria) Mediolanum Farmaceutici (Italy) | PP-001 - 3-{[2,3,5,6-tetrafluoro-3\'-(trifluoromethoxy)biphenyl-4-yl]carbamoyl}thiophene-2-carboxylic acid | inflammatory eye diseases including non-infectious uveitis | licensing |
Ophtalmological diseases - Inflammatory diseases - Rare diseases | Licensing agreement |
| 2015-02-09 | Juno Therapeutics (USA - WA) | cell therapy products including JCAR015 | manufacturing production |
Production agreement | ||
| 2015-02-09 | Kymab (UK) | resignation |
Resignation | |||
| 2015-02-06 | Exact Sciences Corporation (USA - WI) Mayo Clinic (USA - MN) | screening, surveillance and diagnostic tests beyond colorectal cancer addressing diseases within the gastrointestinal tract | diseases within the gastrointestinal tract | collaboration |
Diagnostic - Cancer - Oncology - Gastrointestinal diseases | Collaboration agreement |
| 2015-02-05 | Integragen (France) Genoma SA (Switzerland) | autism spectrum disorder genetic risk assessment test - ARISk® Test | autism | distribution |
CNS diseases - Genetic diseases - Neurological diseases - Rare diseases | Distribution agreement |
